Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Sell
19
SAIC Quote, Financials, Valuation and Earnings
Last price:
$104.97
Seasonality move
:
-2.43%
Day range:
$102.00 - $105.50
52-week range:
$94.68 - $156.34
Dividend yield:
1.42%
P/E ratio:
14.62x
P/S ratio:
0.69x
P/B ratio:
3.25x
Volume:
537.4K
Avg. volume:
688K
1-year change:
-11.17%
Market cap:
$4.9B
Revenue:
$7.5B
EPS (TTM):
$7.13
Analysts' Opinion
-
Consensus RatingScience Applications International has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $120.41, Science Applications International has an estimated upside of 15.55% from its current price of $104.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $92.00 representing 100% downside risk from its current price of $104.21.
Fair Value
-
According to the consensus of 8 analysts, Science Applications International has 15.55% upside to fair value with a price target of $120.41 per share.
SAIC vs. S&P 500
-
Over the past 5 trading days, Science Applications International has underperformed the S&P 500 by -1.88% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Science Applications International does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Science Applications International has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Science Applications International reported revenues of $1.9B.
Earnings Growth
-
Science Applications International earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Science Applications International reported earnings per share of $1.42.
Enterprise value:
7.1B
EV / Invested capital:
1.88x
Price / LTM sales:
0.69x
EV / EBIT:
13.16x
EV / Revenue:
0.95x
PEG ratio (5yr expected):
0.33x
EV / Free cash flow:
15.54x
Price / Operating cash flow:
11.23x
Enterprise value / EBITDA:
10.44x
Gross Profit (TTM):
$888M
Return On Assets:
6.73%
Net Income Margin (TTM):
4.7%
Return On Equity:
21.85%
Return On Invested Capital:
9.3%
Operating Margin:
6.45%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Income Statement | ||||||
| Revenue | $7.7B | $7.3B | $7.5B | $1.8B | $1.9B | |
| Gross Profit | $897M | $850M | $888M | $213M | $209M | |
| Operating Income | $531M | $480M | $551M | $131M | $121M | |
| EBITDA | $678M | $855M | $682M | $164M | $152M | |
| Diluted EPS | $5.88 | $8.54 | $7.13 | $1.48 | $1.42 | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.3B | $1.7B | $1.1B | $1.1B | |
| Total Assets | $5.8B | $5.7B | $6B | $5.3B | $5.2B | |
| Current Liabilities | $1.4B | $1.3B | $1.6B | $1.2B | $1.5B | |
| Total Liabilities | $4.2B | $4.1B | $4.3B | $3.5B | $3.7B | |
| Total Equity | $1.6B | $1.7B | $1.7B | $1.8B | $1.5B | |
| Total Debt | $2.5B | $2.5B | $2.4B | $2.1B | $2.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $496M | $412M | $496M | $98M | $100M | |
| Cash From Investing | $306M | -$29M | -$43M | -$7M | -$15M | |
| Cash From Financing | -$436M | -$756M | -$456M | -$136M | -$94M | |
| Free Cash Flow | $470M | $385M | $458M | $92M | $92M | |
SAIC
Sector
Market Cap
$4.9B
$611.3M
Price % of 52-Week High
66.66%
78.34%
Dividend Yield
1.42%
0%
Shareholder Yield
10.66%
2.29%
1-Year Price Total Return
-11.17%
-1.15%
Beta (5-Year)
0.503
0.777
Dividend yield:
1.42%
Annualized payout:
$1.48
Payout ratio:
20.96%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$104.64
200-day SMA
Sell
Level
$120.24
Bollinger Bands (100)
Sell
Level
103.21 - 118.07
Chaikin Money Flow
Buy
Level
22.6M
20-day SMA
Sell
Level
$107.07
Relative Strength Index (RSI14)
Sell
Level
37.62
ADX Line
Sell
Level
31.88
Williams %R
Neutral
Level
-39.398
50-day SMA
Sell
Level
$114.68
MACD (12, 26)
Sell
Level
-3.25
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
52.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9864)
Buy
CA Score
(Annual)
Level (-0.2693)
Buy
Beneish M-Score
(Annual)
Level (-2.5199)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (1.0682)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer’s entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.
Stock Forecast FAQ
In the current month, SAIC has received 1 Buy ratings 7 Hold ratings, and 0 Sell ratings. The SAIC average analyst price target in the past 3 months is $120.41.
-
Where Will Science Applications International Stock Be In 1 Year?
According to analysts, the consensus estimate is that Science Applications International share price will rise to $120.41 per share over the next 12 months.
-
What Do Analysts Say About Science Applications International?
Analysts are divided on their view about Science Applications International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Science Applications International is a Sell and believe this share price will drop from its current level to $92.00.
-
What Is Science Applications International's Price Target?
The price target for Science Applications International over the next 1-year time period is forecast to be $120.41 according to 8 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is SAIC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Science Applications International is a Hold. 7 of 8 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SAIC?
You can purchase shares of Science Applications International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Science Applications International shares.
-
What Is The Science Applications International Share Price Today?
Science Applications International was last trading at $104.97 per share. This represents the most recent stock quote for Science Applications International. Yesterday, Science Applications International closed at $104.21 per share.
-
How To Buy Science Applications International Stock Online?
In order to purchase Science Applications International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Howard Marks Buy Grab Stock?
When a legendary value investor who cut his teeth in…
Why Did Warren Buffett Buy Amazon Stock?
When investors think of tech stocks in Warren Buffett’s portfolio,…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
88
CDTX alert for Jun 24
Cidara Therapeutics [CDTX] is up 3.18% over the past day.
Sell
46
HIMS alert for Jun 24
Hims & Hers Health [HIMS] is up 2.26% over the past day.
Buy
67
WGS alert for Jun 24
GeneDx Holdings [WGS] is up 13.99% over the past day.
